Published in Parkinsonism Relat Disord on December 06, 2011
Room-temperature ultraviolet nanowire nanolasers. Science (2001) 9.79
DNA replication: the rolling circle model. Cold Spring Harb Symp Quant Biol (1968) 8.37
Electric and magnetic stimulation of human motor cortex: surface EMG and single motor unit responses. J Physiol (1989) 5.69
Adenovirus-2 DNA contains an inverted terminal repetition. Proc Natl Acad Sci U S A (1972) 4.57
A potential noninvasive neurobiological test for Alzheimer's disease. Science (1994) 4.29
Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells. J Immunol (1982) 3.24
Molecular mechanisms in genetic recombination. Annu Rev Biochem (1982) 3.03
Initiation and reinitiation of DNA synthesis during replication of bacteriophage T7. Proc Natl Acad Sci U S A (1972) 2.95
Bacteriophage T7 DNA replication: a linear replicating intermediate (gradient centrifugation-electron microscopy-E. coli-DNA partial denaturation). Proc Natl Acad Sci U S A (1972) 2.87
Structure of erythrocruorin in different ligand states refined at 1.4 A resolution. J Mol Biol (1979) 2.51
Cloning and expression of a receptor for an insecticidal toxin of Bacillus thuringiensis. J Biol Chem (1995) 2.49
Evidence for lysosomal enzyme recognition by human fibroblasts via a phosphorylated carbohydrate moiety. Biochem J (1978) 2.46
Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int (1982) 2.24
On the mechanism of genetic recombination: electron microscopic observation of recombination intermediates. Proc Natl Acad Sci U S A (1976) 2.19
Forest ecosystem development in post-mining landscapes: a case study of the Lusatian lignite district. Naturwissenschaften (2001) 2.17
The amplification of ribosomal RNA genes involves a rolling circle intermediate. Proc Natl Acad Sci U S A (1973) 2.07
CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood (1997) 1.89
Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology (2003) 1.89
dnaG (primase)-dependent origins of DNA replication. Nucleotide sequences of the negative strand initiation sites of bacteriophages St-1, phi K, and alpha 3. J Biol Chem (1979) 1.82
Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med (1988) 1.79
Cathepsin K--a marker of macrophage differentiation? J Pathol (2001) 1.77
Synthesis of interleukin 1/endogenous pyrogen in the brain of endotoxin-treated mice: a step in fever induction? J Immunol (1984) 1.71
Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects. J Immunol (1984) 1.68
An alternative hypothesis of cellular transport of lysosomal enzymes in fibroblasts. Effect of inhibitors of lysosomal enzyme endocytosis on intra- and extra-cellular lysosomal enzyme activities. Biochem J (1978) 1.67
Transfer factor. Ann Intern Med (1974) 1.65
Growth rate of 147 mammary carcinomas. Cancer (1980) 1.62
Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib. Eur J Cancer (2009) 1.62
Raf-1 causes growth suppression and alteration of neuroendocrine markers in DMS53 human small-cell lung cancer cells. Am J Respir Cell Mol Biol (1999) 1.58
CD24, a signal-transducing molecule expressed on human B cells, is a major surface antigen on small cell lung carcinomas. Cancer Res (1992) 1.57
Site-specific initiation of a DNA fragment: nucleotide sequence of the bacteriophage G4 negative-strand initiation site. Proc Natl Acad Sci U S A (1978) 1.57
Tacrolimus oral bioavailability doubles with coadministration of ketoconazole. Clin Pharmacol Ther (1997) 1.55
Effects of subthalamic nucleus (STN) stimulation on motor cortex excitability. Neurology (2002) 1.53
The rolling circle for phiX DNA replication. II. Synthesis of single-stranded circles. Proc Natl Acad Sci U S A (1970) 1.48
Pharmacokinetics of technetium-99m-MAG3 in humans. J Nucl Med (1990) 1.48
Dynamics of drug regimen compliance--its assessment by microprocessor-based monitoring. Eur J Clin Pharmacol (1990) 1.47
A new polymorph of N-phenyl-phthalimide. Acta Crystallogr Sect E Struct Rep Online (2009) 1.43
In vitro system from Escherichia coli that catalyzes generalized genetic recombination. Proc Natl Acad Sci U S A (1978) 1.40
Seasonality in clinical onset of type 1 diabetes in belgian patients above the age of 10 is restricted to HLA-DQ2/DQ8-negative males, which explains the male to female excess in incidence. Diabetologia (2004) 1.40
Latitudinal population differentiation in two species of Solidago (Asteraceae) introduced into Europe. Am J Bot (1998) 1.40
Concentrations of lysosomal cysteine proteases are decreased in renal cell carcinoma compared with normal kidney. J Cancer Res Clin Oncol (1997) 1.38
Regions of single-stranded DNA in the growing points of replicating bacteriophage T7 chromosomes. Proc Natl Acad Sci U S A (1972) 1.37
1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs. Proc Natl Acad Sci U S A (1986) 1.37
Interaction of 6-cyano-7-nitroquinoxaline-2,3-dione with the N-methyl-D-aspartate receptor-associated glycine binding site. Mol Pharmacol (1989) 1.36
Effect of digital nerve stimuli on responses to electrical or magnetic stimulation of the human brain. J Physiol (1992) 1.35
Primary structure of the uracil transport protein of Saccharomyces cerevisiae. Eur J Biochem (1988) 1.31
High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study. J Neural Transm (Vienna) (2004) 1.26
Auditory sustained attention is a marker of unilateral spatial neglect. Neuropsychologia (1997) 1.24
On the mechanism of genetic recombination: the maturation of recombination intermediates. Proc Natl Acad Sci U S A (1977) 1.24
Evaluating the impact of hospitalists. Ann Intern Med (1999) 1.21
Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells. J Exp Med (2001) 1.21
Endothelium-dependent responses in carotid and renal arteries of normotensive and hypertensive rats. Hypertension (1988) 1.19
Analysis of the phiX DNA replication cycle by electron microscopy. Proc Natl Acad Sci U S A (1978) 1.19
The nucleolus and the rolling circle. Cold Spring Harb Symp Quant Biol (1974) 1.17
The rolling circle for phi X DNA replication. 3. Synthesis of supercoiled duplex rings. Proc Natl Acad Sci U S A (1970) 1.17
Activated Raf-1 causes growth arrest in human small cell lung cancer cells. J Clin Invest (1998) 1.17
Nonlinear mezlocillin kinetics due to dose-dependent metabolism. Clin Pharmacol Ther (1983) 1.16
Patterns of drug compliance with medications to be taken once and twice daily assessed by continuous electronic monitoring in primary care. Int J Clin Pharmacol Ther (1994) 1.16
Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations. Eur J Neurol (2006) 1.15
Candida and "20th-century disease". CMAJ (1985) 1.15
Automated examination notification of emergency department images in a picture archiving and communication system. J Digit Imaging (2001) 1.14
Monoclonal antibody to the message sequence Tyr-Gly-Gly-Phe of opioid peptides exhibits the specificity requirements of mammalian opioid receptors. Proc Natl Acad Sci U S A (1983) 1.14
Predominance of the amino-terminal octapeptide fragment of dynorphin in rat brain regions. Nature (1982) 1.12
Biochemical assay designed to detect formation of recombination intermediates in vitro. Proc Natl Acad Sci U S A (1979) 1.11
Activity, expression, and transcription rate of the cathepsins B, D, H, and L in cutaneous malignant melanoma. Cancer (2001) 1.11
Citation characteristics of research published in Emergency Medicine versus other scientific journals. Ann Emerg Med (2001) 1.11
Risk factors for adverse drug reactions--epidemiological approaches. Eur J Clin Pharmacol (1990) 1.11
The pharmacokinetics and metabolic disposition of tacrolimus: a comparison across ethnic groups. Clin Pharmacol Ther (2001) 1.09
Expression of opioid peptides in tumors. N Engl J Med (1987) 1.09
Complete secondary botulinum toxin therapy failure in blepharospasm. J Neurol (2000) 1.07
Immunohistochemical distribution of alpha-neo-endorphin/dynorphin neuronal systems in rat brain: evidence for colocalization. Proc Natl Acad Sci U S A (1982) 1.07
Transcranial electric and magnetic stimulation of the leg area of the human motor cortex: single motor unit and surface EMG responses in the tibialis anterior muscle. Electroencephalogr Clin Neurophysiol (1993) 1.07
Cathepsin S and an asparagine-specific endoprotease dominate the proteolytic processing of human myelin basic protein in vitro. Eur J Immunol (2001) 1.07
Crystallization, crystal structure analysis and molecular model of the third domain of Japanese quail ovomucoid, a Kazal type inhibitor. J Mol Biol (1981) 1.06
Phencyclidine and psychotomimetic sigma opiates: recent insights into their biochemical and physiological sites of action. Trends Neurosci (1988) 1.05
Further observations on the facilitation of muscle responses to cortical stimulation by voluntary contraction. Electroencephalogr Clin Neurophysiol (1991) 1.04
Noncyclic crown-type polyethers, pyridinophane cryptands, and their alkali metal ion complexes: synthesis, complex stability, and kinetics. J Am Chem Soc (1977) 1.04
Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells. Biochem Biophys Res Commun (1990) 1.04
Active therapy for chronic low back pain: part 2. Effects on paraspinal muscle cross-sectional area, fiber type size, and distribution. Spine (Phila Pa 1976) (2001) 1.03
Influence of age and duration of symptoms on fibre type distribution and size of the back muscles in chronic low back pain patients. Eur Spine J (2000) 1.03
Design and synthesis of rhodamine 110 derivative and caspase-3 substrate for enzyme and cell-based fluorescent assay. Bioorg Med Chem Lett (2001) 1.03
A 'Southern Cross' method for the analysis of genome organization and the localization of transcription units. Gene (1986) 1.02
Transfer factor: a subcellular component that transmits information for specific immune responses. Proc Natl Acad Sci U S A (1974) 1.02
Effect of low- and high-fat meals on tacrolimus absorption following 5 mg single oral doses to healthy human subjects. J Clin Pharmacol (2001) 1.02
The retinoblastoma tumor suppressor inhibits cellular proliferation through two distinct mechanisms: inhibition of cell cycle progression and induction of cell death. Oncogene (1999) 1.02
Crystallographic refinement of Japanese quail ovomucoid, a Kazal-type inhibitor, and model building studies of complexes with serine proteases. J Mol Biol (1982) 1.02
Identification of pro-opiomelanocortin-derived peptides in the human adrenal medulla. Science (1983) 1.02
Induction of drug metabolizing enzymes by sulfinpyrazone. Eur J Clin Pharmacol (1981) 1.02
Novel peptide neuronal system in rat brain and pituitary. Science (1981) 1.01
Nerve growth factor induces neuron-like differentiation of an insulin-secreting pancreatic beta cell line. Proc Natl Acad Sci U S A (1993) 1.01
Antibodies specific for alpha-N-acetyl-beta-endorphins: radioimmunoassays and detection of acetylated beta-endorphins in pituitary extracts. J Neurochem (1982) 1.00
Risk factors as reflected by an intensive drug monitoring system. Agents Actions Suppl (1990) 1.00
Image reconstructions with the rotating RF coil. J Magn Reson (2009) 1.00
Dosage frequency and drug-compliance behaviour--a comparative study on compliance with a medication to be taken twice or four times daily. Eur J Clin Pharmacol (1991) 1.00
Colocalization of alpha-neo-endorphin and dynorphin immunoreactivity in hypothalamic neurons. Biochem Biophys Res Commun (1981) 1.00
IL-1 beta- and IL-4-induced down-regulation of autotaxin mRNA and PC-1 in fibroblast-like synoviocytes of patients with rheumatoid arthritis (RA). Clin Exp Immunol (2001) 0.99
On the chemical nature of transfer factor. Proc Natl Acad Sci U S A (1974) 0.98
Astrocytes as antigen-presenting cells. Part II: Unlike H-2K-dependent cytotoxic T cells, H-2Ia-restricted T cells are only stimulated in the presence of interferon-gamma. J Neuroimmunol (1986) 0.97
Immunoreactive dynorphin-(1-8) and corticotropin- releasing factor in subpopulation of hypothalamic neurons. Science (1983) 0.97
Pharmacology of botulinum toxin: differences between type A preparations. Eur J Neurol (2006) 0.97
A method for testing the specificity of influenza A virus-reactive memory cytotoxic T lymphocyte (CTL) clones in limiting dilution cultures. J Immunol Methods (1984) 0.97